ARCHIVES

ODAC Recommends Ethyol, DaunoXome For FDA Approval

This article is from The Cancer Letter archive.

Vol. 21 No. 24 | June 16, 1995

Download PDF Visit The Full Archive

Related Articles

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

NIH Considering Longer grant Award Periods; CCIRC’s New Bosses Crack Dow On Conferences

November 10, 1978

2013 Appropriations: Additional Level of Grant Review Proposed As NIH Prepares For Cost Cutting

March 30, 2012

NCI Programs: Report Calls for Expansion of Colorectal Cancer Research

April 28, 2000

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979